An adverse outcome pathway for chemical-induced Parkinson's disease: Calcium is key

被引:1
作者
Meerman, Julia J. [1 ,2 ]
Legler, Juliette [2 ]
Piersma, Aldert H. [1 ,2 ]
Westerink, Remco H. S. [2 ]
Heusinkveld, Harm J. [1 ]
机构
[1] Dutch Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, Antonie van Leeuwenhoeklaan 9, NL-3721 MA Bilthoven, Netherlands
[2] Univ Utrecht, Inst Risk Assessment Sci IRAS, Fac Vet Med, Utrecht, Netherlands
关键词
Adverse Outcome Pathway; Next generation risk assessment; Pesticides; Parkinson's disease; Intracellular calcium concentration; ENDOPLASMIC-RETICULUM STRESS; ROTENONE RAT MODEL; INDUCED OXIDATIVE STRESS; PROTECTS SH-SY5Y CELLS; NIGRA DOPAMINE NEURONS; SUBSTANTIA-NIGRA; INDUCED NEUROTOXICITY; IN-VITRO; MITOCHONDRIAL DYSFUNCTION; BEHAVIORAL DEFICITS;
D O I
10.1016/j.neuro.2023.11.001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Exposure to pesticides is associated with an increased risk of developing Parkinson's disease (PD). Currently, rodent-based risk assessment studies cannot adequately capture neurodegenerative effects of pesticides due to a lack of human-relevant endpoints targeted at neurodegeneration. Thus, there is a need for improvement of the risk assessment guidelines. Specifically, a mechanistic assessment strategy, based on human physiology and (patho)biology is needed, which can be applied in next generation risk assessment. The Adverse Outcome Pathway (AOP) framework is particularly well-suited to provide the mechanistic basis for such a strategy. Here, we conducted a semi-systematic review in Embase and MEDLINE, focused on neurodegeneration and pesticides, to develop an AOP network for parkinsonian motor symptoms. Articles were labelled and included/excluded using the online platform Sysrev. Only primary articles, written in English, focused on effects of pesticides or PD model compounds in models for the brain were included. A total of 66 articles, out of the 1700 screened, was included. PD symptoms are caused by loss of function and ultimately death of dopaminergic neurons in the substantia nigra (SN). Our literature review highlights that a unique feature of these cells that increases their vulnerability is their reliance on continuous low-level influx of calcium. As such, excess intracellular calcium was identified as a central early Key Event (KE). This KE can lead to death of dopaminergic neurons of the SN, and eventually parkinsonian motor symptoms, via four distinct pathways: 1) activation of calpains, 2) endoplasmic reticulum stress, 3) impairment of protein degradation, and 4) oxidative damage. Several receptors have been identified that may serve as molecular initiating events (MIEs) to trigger one or more of these pathways. The proposed AOP network provides the biological basis that can be used to develop a mechanistic testing strategy that captures neurodegenerative effects of pesticides.
引用
收藏
页码:226 / 243
页数:18
相关论文
共 50 条
[31]   Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease [J].
Cali, Tito ;
Ottolini, Denis ;
Brini, Marisa .
BIOFACTORS, 2011, 37 (03) :228-240
[32]   Voltage-gated calcium channels and Parkinson's disease [J].
Hurley, Michael J. ;
Dexter, David T. .
PHARMACOLOGY & THERAPEUTICS, 2012, 133 (03) :324-333
[33]   Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease [J].
Struzyna, Laura A. ;
Browne, Kevin D. ;
Brodnik, Zachary D. ;
Burrell, Justin C. ;
Harris, James P. ;
Chen, H. Isaac ;
Wolf, John A. ;
Panzer, Kate V. ;
Lim, James ;
Duda, John E. ;
Espana, Rodrigo A. ;
Cullen, D. Kacy .
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2018, 12 (07) :1702-1716
[34]   Gene therapy targeting mitochondrial pathway in Parkinson’s disease [J].
Chi-Jing Choong ;
Hideki Mochizuki .
Journal of Neural Transmission, 2017, 124 :193-207
[35]   Neurotoxicity of Key Metals in Parkinson's Disease [J].
Huang, Hui ;
Chen, Jun ;
Lu, Huiru ;
Zhou, Mengxue ;
Hu, Yi ;
Chai, Zhifang .
PROGRESS IN CHEMISTRY, 2018, 30 (10) :1592-1600
[36]   Challenge for Adverse Outcome Pathway (AOP)-based Chemical Safety Assessment [J].
Yamada, Takashi ;
Ashikaga, Takao ;
Kojima, Hajime ;
Hirose, Akihiko .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2020, 140 (04) :481-484
[37]   Adverse outcome pathway:Framework,application,and challenges in chemical risk assessment [J].
Bingsheng Zhou .
Journal of Environmental Sciences, 2015, 35 (09) :191-193
[38]   Using the Gene Ontology to Annotate Key Players in Parkinson's Disease [J].
Foulger, R. E. ;
Denny, P. ;
Hardy, J. ;
Martin, M. J. ;
Sawford, T. ;
Lovering, R. C. .
NEUROINFORMATICS, 2016, 14 (03) :297-304
[39]   The key role of T cells in Parkinson's disease pathogenesis and therapy [J].
Baird, Jill K. ;
Bourdette, Dennis ;
Meshul, Charles K. ;
Quinn, Joseph F. .
PARKINSONISM & RELATED DISORDERS, 2019, 60 :25-31
[40]   Chemical management of levodopa-induced dyskinesia in Parkinson's disease patients [J].
Dragasevic-Miskovic, Natasa ;
Petrovic, Igor ;
Stankovic, Iva ;
Kostic, Vladimir S. .
EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (02) :219-230